14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TRVN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Trevena stock price ended at $0.381 on Wednesday, after losing 1.80%.
(Updated on Apr 24, 2024)

Sell candidate since Mar 11, 2024 Loss -32.57% PDF

The Trevena stock price fell by -1.80% on the last day (Wednesday, 24th Apr 2024) from $0.388 to $0.381. During the last trading day the stock fluctuated 7.14% from a day low at $0.364 to a day high of $0.390. The price has risen in 6 of the last 10 days but is still down by -6.16% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -81 thousand shares and in total, 61 thousand shares were bought and sold for approximately $23.27 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.43% during the next 3 months and, with a 90% probability hold a price between $0.201 and $0.257 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TRVN Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 8.24%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Trevena stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.455. On a fall, the stock will find some support from the short-term average at $0.379. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Trevena stock

Trevena finds support from accumulated volume at $0.371 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0260 between high and low, or 7.14%. For the last week the stock has had daily average volatility of 14.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TRVN) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Trevena to open at $0.378, and during the day (based on 14 day Average True Range), to move between $0.339 and $0.423, which gives a possible trading interval of +/-$0.0418 (+/-10.98%) up or down from last closing price. If Trevena takes out the full calculated possible swing range there will be an estimated 21.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.371 (2.55%) than the resistance at $0.400 (4.99%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Trevena stock A Buy?

Trevena holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.566 Sell Candidate Unchanged

Predicted Opening Price for Trevena of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$0.378 ( 0.717%) $0.381

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TRVN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.404 6.11 %
R2 0.394 3.50 %
R1 0.388 1.89 %
Current price: 0.381
Support S1 0.368 -3.32 %
S2 0.362 -4.93 %
S3 0.352 -7.54 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.460 20.73 %
R2 0.402 5.51 %
R1 0.400 4.99 %
Current price 0.381
Support S1 0.371 -2.55%
S2 0.370 -2.83%
S3 0.366 -3.94%

FAQ

What is the symbol for Trevena Stock and on which exchange is it traded?
The symbol for Trevena is TRVN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Trevena Stock?
Trevena holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Trevena Stock?
Trevena Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Trevena Stock.

What's the current price of Trevena Stock?
As of the end of day on the Apr 24, 2024, the price of an Trevena (TRVN) share was $0.381.

What is the 52-week high and low for Trevena Stock?
The 52-week high for Trevena Stock is $3.28 and the 52-week low is $0.300.

What is the market capitalization of Trevena Stock?
As of the Apr 24, 2024, the market capitalization of Trevena is 5.887M.

When is the next earnings date for Trevena?
The upcoming earnings date for Trevena is May 13, 2024.
Click to get the best stock tips daily for free!

About Trevena

Trevena Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abno... TRVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT